Boston Scientific Corporation vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8.7
Very Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
BSX
Clean balance sheet with low leverage (0.4× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $85.19 (+50.8%)
32 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
BSX
PFE
23.6×
Trailing P/E
19.4×
15.0×
Forward P/E
9.4×
17.3%
Profit Margin
12.4%
68.9%
Gross Margin
75.8%
14.7%
ROE
8.9%
11.6%
Revenue Growth
-1.2%
100.0%
Earnings Growth
—
0.78
Beta
0.39
—
Price / Book
—
$84.0B
Market Cap
$149.8B
$56 – $110
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →